Dr. Marco Sgarbanti is a Senior Researcher at the Istituto Superiore di Sanità. He graduated cum laude in Biological Sciences at the University of Rome “La Sapienza", with an experimental thesis titled: "Role of IRFs transcription factors in the regulation of IFN-induced gene expression". From April 1998 to April 2000, he worked with a research contract at ISS, in the Virology Laboratory. During this period, he developed his research project, which had the objective of studying the interactions between Interferon regulatory factors (IRFs) and HIV-1 proteins in HIV-1 infection of CD4+ T cells. From April 2000 to January 2003, he worked at the Lady Davis Institute for Medical Research, McGill University, Montreal, Canada, in the laboratory of Prof. John Hiscott, to study the role of the NF-kappaB transcription factor in the lytic reactivation of HHV-8. In 2002, he obtained a permanent researcher position at the ISS and in April 2008 he obtained the title of Ph.D. in Immunology at the University of Rome “Tor Vergata" with a thesis titled: "Transcription and regulation of the HIV-1 Long Terminal Repeat promoter by  cellular factors in CD4+ T cells". Since 2012 he has been a permanent researcher at the Department of Infectious, Parasitic, and Immuno-Mediated Diseases, now the Department of Infectious Diseases (DMI), of the ISS. Since 2022, he has held a permanent Senior Researcher position at the DMI of ISS.